The compound effectively inhibited TNF-α, IL-1β, and IL-6 levels in myocardial ischemia–reperfusion models while suppressing necroptosis through transforming growth factor-beta-activated kinase 1 (TAK1) phosphorylation regulation. This evidence concerns the gene MAP3K7 and myocardial ischemia.